Dazhi Liu

Also affiliated with Northern General Hospital

MedicineComputer ScienceBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 12 papers. Top paper: “Central Nervous System Disease in Patients With RET Fusion-Positive NSCLC Treated With Selpercatinib”.

Central Nervous System Disease in Patients With RET Fusion-Positive NSCLC Treated With Selpercatinib

Journal of Thoracic Oncology(2023)10.1016/j.jtho.2023.01.008

N/A

0.982DataRank · unranked

21 citations

Christina J. Falcon, Sabrina T. Lin, Christina Chacko, Grace Grimaldi, Dazhi Liu +4 more

Final analysis of multi-histology basket trial expansion of ado-trastuzumab emtansine in patients with HER2 amplified cancers.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.3025

N/A

0.345DataRank · unranked

9 citations

Vicky Makker, Darren J. Buonocore, Ronglai Shen, Rona Yaeger, Michelle S. Ginsberg +15 more

Clinical outcomes of immune checkpoint inhibitors in HER2-amplified non-small cell lung cancers.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.e21098

N/A

0.330DataRank · unranked

8 citations

Debra A. Goldman, Sabrina T. Lin, Darren J. Buonocore, Jianjiong Gao, Jason C. Chang +15 more

Central nervous system (CNS) outcomes and progression patterns in patients with RET fusion-positive lung cancers treated with selpercatinib.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.3109

N/A

0DataRank · unranked

1 citations

Christina J. Falcon, Sabrina T. Lin, Aradhika Dhawan, Grace Grimaldi, Dazhi Liu +5 more

Clinicopathologic characterization of ERK2 E322K mutation in solid tumors: Implications for treatment and drug development.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.3135

N/A

0DataRank · unranked

0 citations

Yonina R. Murciano‐Goroff, Justin Jee, Maria E. Arcila, Darren J. Buonocore, Jianjiong Gao +15 more

Sodium-Glucose Cotransporter-2 Inhibitors for Hyperglycemia in Phosphoinositide 3-kinase Pathway Inhibition

Research Square(2023)10.21203/rs.3.rs-2655905/v1

N/A

0DataRank · unranked

2 citations

Dazhi Liu, Raymond G. Dematteo, Marcus D. Goncalves, James Flory, Michael A. Weintraub

EGFR-directed antibodies promote HER2 ADC internalization and efficacy

Cell Reports Medicine(2024)10.1016/j.xcrm.2024.101792

N/A

0DataRank · unranked

31 citations

Flavia Michelini, Hong Shao, Celine Yeh, Joshua Z. Drago, Dazhi Liu +12 more

Diverse ERBB2/ERBB3 Activating Alterations and Coalterations Have Implications for HER2/3-Targeted Therapies across Solid Tumors

Cancer Research Communications(2025)10.1158/2767-9764.crc-24-0620

N/A

0DataRank · unranked

8 citations

Justin Jee, Alexander Drilon, Andreas M. Heilmann, Justin M. Allen, Alexa B. Schrock +3 more

Brief Report: Chylothorax and Chylous Ascites During RET Tyrosine Kinase Inhibitor Therapy

Journal of Thoracic Oncology(2022)10.1016/j.jtho.2022.06.008

N/A

0DataRank · unranked

47 citations

Christina J. Falcon, Christine M. Bestvina, Dazhi Liu, Lauren A. Kaplanis, Clare Wilhelm +12 more

Mucocutaneous Adverse Events in Patients With Cancer Treated with the Highly Selective RET Kinase Inhibitor Selpercatinib (LOXO-292)

JTO Clinical and Research Reports(2025)10.1016/j.jtocrr.2025.100792

N/A

0DataRank · unranked

3 citations

Rose Parisi, Guilherme Harada, Andrea P. Moy, George Dranitsaris, Jasmine H. Francis +7 more

Mechanisms of acquired resistance to TRK inhibitors.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.3104

N/A

0DataRank · unranked

17 citations

Noura J. Choudhury, Alison M. Schram, Ezra Y. Rosen, Yonina R. Murciano‐Goroff, Christina J. Falcon +13 more

Chylothorax and chylous ascites during RET tyrosine kinase inhibitor therapy.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.9080

N/A

0DataRank · unranked

3 citations

Christina J. Falcon, Christine M. Bestvina, Dazhi Liu, Lauren A. Kaplanis, Clare Wilhelm +11 more